Preoperative Screening/Decolonization for Staphylococcus aureus to Prevent Orthopedic Surgical Site Infection. Prospective Cohort Study With 2-Year Follow-Up

Journal of Arthroplasty

Volumn 26, Issue 8, 2011, Pages 1501-1507

  Rao, Nalini ^a   Cannella, Barbara A ^a   Crossett, Lawrence S ^a   Yates, Adolph J ^a   McGough, Richard L ^a   Hamilton, Cindy W ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Virginia Beach   (United States)

Author keywords

Chlorhexidine; Decolonization; Mupirocin; Screening; Surgical site infection; Total joint arthroplasty

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; INFECTION RATE; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; NONHUMAN; PERIOPERATIVE PERIOD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL SITE INFECTION;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CHLORHEXIDINE; COHORT STUDIES; FOLLOW-UP STUDIES; HIP JOINT; HUMANS; KNEE JOINT; MASS SCREENING; MUPIROCIN; PREOPERATIVE CARE; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 80755175697     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.03.014     Document Type: Article

References (32)

1. Bozic K.J., Kurtz S.M., Lau E., et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010, 468:45.
2. Whitehouse J.D., Friedman N.D., Kirkland K.B., et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002, 23:183.
3. Kurtz S.M., Lau E., Schmier J., et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008, 23:984.
4. de Lissovoy G., Fraeman K., Hutchins V., et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009, 37:387.
5. Edwards C., Counsell A., Boulton C., et al. Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 2008, 90:770.
6. Monge Jodra V., Sainz de Los Terreros Soler L., Diaz-Agero Perez C., et al. Excess length of stay attributable to surgical site infection following hip replacement: a nested case-control study. Infect Control Hosp Epidemiol 2006, 27:1299.
7. Kurtz S.M., Ong K.L., Lau E., et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010, 468:52.
8. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250.
9. Anderson D.J., Sexton D.J., Kanafani Z.A., et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007, 28:1047.
10. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10:505.
11. Perl T.M., Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Annals Pharmacother 1998, 32:S7.
12. Wenzel R.P., Perl T.M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hospital Infect 1995, 31:13.
13. Kalmeijer M.D., van Nieuwland-Bollen E., Bogaers-Hofman D., et al. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000, 21:319.
14. Gernaat-van der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., et al. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthopaedica Scand 1998, 69:412.
15. Nixon M., Jackson B., Varghese P., et al. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br 2006, 88:812.
16. Hacek D.M., Robb W.J., Paule S.M., et al. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008, 466:1349.
17. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35:353.
18. Kaiser A.B., Kernodle D.S., Barg N.L., et al. Influence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Annals Thoracic Surg 1988, 45:35.
19. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9.
20. Rao N., Cannella B., Crossett L.S., et al. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008, 466:1343.
21. D'Souza H.A., Baron E.J. BBL CHROMagar Staph aureus is superior to mannitol salt for detection of Staphylococcus aureus in complex mixed infections. Am J Clin Pathol 2005, 123:806.
22. Flayhart D., Hindler J.F., Bruckner D.A., et al. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 2005, 43:5536.
23. Sculco T.P. The economic impact of infected total joint arthroplasty. Instruct Course Lectures 1993, 42:349.
24. Perl T.M. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 2003, 134(5 Suppl):S10.
25. Kim D.H., Spencer M., Davidson S.M., et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg 2010, 92:1820.
26. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871.
27. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149.
28. Leski T.A., Gniadkowski M., Skoczynska A., et al. Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J Clin Microbiol 1999, 37:2781.
29. Deshpande L.M., Fix A.M., Pfaller M.A., et al. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 2002, 42:283.
30. Batra R., Cooper B.S., Whiteley C., et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50:210.
31. Ammerlaan H.S., Kluytmans J.A., Wertheim H.F., et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922.
32. Archived consumer price index detailed report information 2010, Bureau of Labor Statistics, http://www.bls.gov/cpi/cpi_dr.htm#2010. Accessed 4/4/11.